Literature DB >> 9673792

Opioid receptor and peptide mRNA expression in proliferative zones of fetal rat central nervous system.

F M Leslie1, Y Chen, U H Winzer-Serhan.   

Abstract

There is increasing evidence to suggest that opioid peptides may have widespread effects as regulators of growth. To evaluate the hypothesis that endogenous opioids control cellular proliferation during neural development, we have used in situ hybridization to examine opioid peptide and receptor mRNA expression in neuroepithelial zones of fetal rat brain and spinal cord. Our data show that proenkephalin mRNA is widely expressed in forebrain germinal zones and choroid plexus during the second half of gestation. In contrast, prodynorphin mRNA expression is restricted to the periventricular region of the ventral spinal cord. Little mu or delta receptor mRNA expression was detected in any regions of neuronal proliferation prior to birth. However, kappa receptor mRNA is widely expressed in hindbrain germinal zones during the 3rd week of gestation. Our present findings support the hypothesis that endogenous opioids may regulate proliferation of both neuronal and non-neuronal cells during central nervous system development. Given the segregated expression of proenkephalin mRNA in forebrain neuroepithelium and kappa receptor mRNA within hindbrain, different opioid mechanisms may regulate cell division in rostral and caudal brain regions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673792

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  15 in total

Review 1.  Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability.

Authors:  Kurt F Hauser; Valeriya K Khurdayan; Robin J Goody; Avindra Nath; Alois Saria; James R Pauly
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

2.  Differential effects of opioid and adrenergic agonists on proliferation in a cultured cell line.

Authors:  D Agarwal; J A Glasel
Journal:  Cell Prolif       Date:  1999-08       Impact factor: 6.831

3.  Opioid system diversity in developing neurons, astroglia, and oligodendroglia in the subventricular zone and striatum: impact on gliogenesis in vivo.

Authors:  A Stiene-Martin; P E Knapp; K Martin; J A Gurwell; S Ryan; S R Thornton; F L Smith; K F Hauser
Journal:  Glia       Date:  2001-10       Impact factor: 7.452

4.  Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of mu and delta receptor activation on proliferation and neurite elongation.

Authors:  K F Hauser; A A Houdi; C S Turbek; R P Elde; W Maxson
Journal:  Eur J Neurosci       Date:  2000-04       Impact factor: 3.386

5.  Glial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro.

Authors:  S K Buch; V K Khurdayan; S E Lutz; P E Knapp; N El-Hage; K F Hauser
Journal:  Neuroscience       Date:  2007-05-02       Impact factor: 3.590

Review 6.  Endogenous morphine/nitric oxide-coupled regulation of cellular physiology and gene expression: implications for cancer biology.

Authors:  George B Stefano; Richard M Kream; Kirk J Mantione; Melinda Sheehan; Patrick Cadet; Wei Zhu; Thomas V Bilfinger; Tobias Esch
Journal:  Semin Cancer Biol       Date:  2007-12-08       Impact factor: 15.707

7.  Maternal oral consumption of morphine increases Bax/Bcl-2 ratio and caspase 3 activity during early neural system development in rat embryos.

Authors:  Shiva Nasiraei-Moghadam; Behrang Kazeminezhad; Leila Dargahi; Abolhassan Ahmadiani
Journal:  J Mol Neurosci       Date:  2009-11-21       Impact factor: 3.444

8.  Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats.

Authors:  M R Ebrahimkhani; S Kiani; F Oakley; T Kendall; A Shariftabrizi; S M Tavangar; L Moezi; S Payabvash; A Karoon; H Hoseininik; D A Mann; K P Moore; A R Mani; A R Dehpour
Journal:  Gut       Date:  2006-03-16       Impact factor: 23.059

Review 9.  Cannabinoids and gene expression during brain development.

Authors:  Javier Fernández-Ruiz; María Gómez; Mariluz Hernández; Rosario de Miguel; José A Ramos
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

10.  Volume transmission of beta-endorphin via the cerebrospinal fluid; a review.

Authors:  Jan G Veening; Peter O Gerrits; Henk P Barendregt
Journal:  Fluids Barriers CNS       Date:  2012-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.